KCR’s Post

LBCS will be part of the revolution in nanotechnology in medicine, revolutionizing treatment and diagnosis. Nanotechnology is transforming medicine with significant advancements: Targeted Drug Delivery: Nanoparticles deliver drugs directly to diseased cells, reducing side effects. Nanorobots: Tiny robots navigate the bloodstream to diagnose and treat diseases at the cellular level. Biosensors: Nanoscale sensors detect disease biomarkers for real-time health monitoring. Regenerative Medicine: Nanoscaffolds support tissue and organ regeneration. Imaging and Diagnostics: Nanoparticles enhance imaging techniques for early and accurate diagnoses. LBCS Software Company’s Contribution: LBCS Software predicts and facilitates these advancements through: AI and Data Analytics: Predicts disease patterns and treatment outcomes. Simulation Tools: Models nanoparticle behavior in biological systems. Collaboration Platforms: Connects researchers, clinicians, and industry partners. Regulatory Compliance: Ensures new technologies meet safety standards. Future Roadmaps: Guides the industry towards impactful innovations. #Nanomedicine #Nanotechnology #HealthcareInnovation #TargetedDrugDelivery #Nanorobots #Biosensors #RegenerativeMedicine #MedicalImaging #LBCSSoftware #AIinMedicine #FutureOfHealthcare #MedicalAdvancements #NanotechRevolution #PersonalizedMedicine #HealthcareTechnology

CCAMP developed Optidrop technology brings in new miniaturization possibilities at single-cell resolution to cell interrogation by combining the power of flow cytometry and droplet microfluidics using an on-chip optical fibre enabled sensing mechanism. Read more https://lnkd.in/gXc8NYPa via Phys.org Optidrop is the world's first droplet cytometer with single-cell resolution for multiplexed fluorescence sensing. Droplet microfluidics has the potential to revolutionize diagnostics, genomics and drug discovery by bringing high-throughput analysis of single-cell and analytes within reach. But it has been so far largely untapped due to bulky, expensive imaging or flow cytometry sensing platforms. Optidrop will change this. Patent 1 granted in USA, Eurasia. PCT for patent 2 in USA, EP, India Excited yet? We are inviting licensing interests. If you are interested to know more, please reach out to the C-CAMP Office of Technology Transfer (#OTT): 📧 [email protected] 📞080 6718 5322 Work was done in collaboration with Indian Institute of Technology, Madras with support from DBT BIRAC Department Of Biotechnology, Government Of india Taslimarif Saiyed, PhD Beckman Coulter Diagnostics Beckman Coulter Life Sciences Leica Microsystems MiNaLab - Microsystems and Nanotechnology OOFELIE::Multiphysics for MEMS & Microsystems

Check out this new interview from Comité Scientifique Pro Anima with Emulate Scientific Founder Don Ingber, PhD, where he answers questions about #OrganChips, the work being done with them, and how the technology is reshaping the landscape of drug discovery and development: https://bit.ly/4aH6dsy

Lactocore Group joins NVIDIA Inception Program! I am eager to see how this collaboration will lead to new discoveries and help us push the boundaries of biotechnology. Stay tuned for more updates as we continue to innovate in the realm of peptide therapeutics! #AI #Reptide

Redefining Clinical Trials: The Ethical & Efficient Power of Organ-on-a-Chip" 🚀💡 Ever dreamt of mini replicas of human organs or even entire organisms, all on a microchip? It's becoming reality, heralding a transformative moment in medical research. 🌟 🔹 Organ-on-a-Chip: This innovation involves microfluidic devices with chambers lined by living human cells, mimicking actual organ structures and functions. Who are the leaders in this brave frontier ? Emulate, Inc.(US) 🧫 - With their Emulate Bio platform, they're modeling human biology for drug tests. 💊🔍 CN Bio (UK) 🌐 - Crafting microchips that replicate vital organs like the liver 🫒 and lungs 🫁. MIMETAS (Netherlands) 🧪 - Designing OrganoPlates that brilliantly capture tissue interfaces and showcase human physiology 🧬. TissUse GmbH (Germany)🔗 - Merging multiple organ chips, simulating intricate bodily interactions and ADME processes. 🔄🤖 Nagi Bioscience (Switzerland) 🔬- Pushing boundaries with Organism-on-Chips. They’ve combined robotics, imaging, and microfluidics in their SydLab One platform, using worms as model organisms.🐛 🌉 💡 Why It Matters: These technologies are not just scientific marvels. Their rise could usher in more precise preclinical testing, pushing medical research into a new age of accuracy and reducing the dependency on animal models. 💪 Empowering Innovation: Beyond drug testing, these innovations dive deeper into disease comprehension, individualized treatment options, and unveil life-saving potential. 😎The future of healthcare is looking bright! These innovators are bringing groundbreaking changes to medicine - lighting the way to better health for all #clinicaltrials #OrganOnAChip #biotech

As nanotechnology advances rapidly in healthcare, a critical question emerges: Can traditional software testing methodologies keep pace? These microscopic marvels pose unique challenges and require innovative testing approaches. Read this blog that delves into how meticulous testing protocols and advanced simulations ensure reliable software for nanomedical devices and nanoscale data processing. Praveen Raj #LifeSciences #Nanotechnology #SoftwareTesting

Researchers at the Wyss Institute have developed two methods for building arbitrarily shaped nanostructures using DNA, with a focus on translating the technology towards nanofabrication and drug delivery applications. The combination of DNA nanostructures’ ability to be accurately patterned at the nanoscale, its simplicity in being pre-programmed for rapid assembly within hours, and its capability to integrate thousands of DNA components into complex architectures all make it an attractive method for nanofabrication. #DNA #Nanotechnlogy #DrugDelivery https://bit.ly/3UWkop3

One radioactive particle can be localized and tracked in three dimensions using PEPT technology in large, dense, and/or optically opaque systems that are challenging to study with other techniques. The technology has not yet been adapted for use in biomedical applications; instead, it is currently used to study flows within complex mechanical systems, such as large engines, industrial mixers, etc.

💡 Why don't we use the same mechanisms as cells for delivering proteins and nucleic acids to distal cells? Exosomes have shown tremendous potential for targeted treatments. However, their usefulness is limited by several factors: 🔻 Need for massive production for human therapies: Isolating pure exosomes from biological media or cell cultures is challenging, making large-scale production difficult. 🔻 Low isolation yields: The complex nature of exosomes makes it difficult to obtain high quantities during isolation. 🔻 Poor drug loading: Exosomes have a limited capacity to naturally carry therapeutic cargo. 🔻 Short storage stability: Exosomes naturally degrade over time, limiting their shelf life. 🔻 Safety: While generally safe, potential immune responses or unforeseen interactions with the body's natural processes require further investigation. Nanotechnology emerges as a powerful tool to overcome these hurdles. ✅ By developing exosome-like systems based on natural components, researchers can create delivery vehicles with enhanced properties. ✅ Nanotechnology can also help to understand how exosomes work. Studying interaction with cells could lead to new ways to diagnose diseases, and open doors to entirely new treatments. ✅ DIVERSA, a spin-off company specialized in nanotech for drug delivery,  offers innovative nanoparticle reagents specifically designed to deliver proteins and nucleic acids such as siRNA or mRNA, or even combinations of these, directly into cells. Do you want to know more? Read our latest blog! https://lnkd.in/dy4PqMri #exosomes #personalizedmedicine #lipidnanoparticles #delivery #nanotechnology